Sicklick JK, Babicky M: Resection of non-adenomatous gastric tumors. Operative Endoscopic and Minimally Invasive Surgery. : 2017 (in press).
Cavnar MJ: Perspective on gastrointestinal stromal tumors. Magnicot's Abdominal Operations, 13th Edition. : 2017 (in press).
Cavnar MJ, Turcotte S, Katz SC, Kuk D, Gönen M, Shia J, Allen PJ, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR: Tumor-associated macrophage infiltration in colorectal cancer liver metastases is associated with better outcome. Ann Surg Oncol 24 (7): 1835-1842,2017.
Groot Koerkamp B, Sadot E, Kemeny NE, Gönen M, Leal JN, Allen PJ, Cercek A, DeMatteo RP, Kingham TP, Jarnagin WR: Perioperative hepatic arterial infusion pump chemotherapy is associated with longer survival after resection of colorectal liver metastases: A propensity score analysis. J Clin Oncol 35 (17): 1938-1944,2017.
Creasy JM, Goldman DA, Dudeja V, Lowery MA, Cercek A, Balachandran VP, Allen PJ, DeMatteo RP, Kingham TP, D'Angelica MI: Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: Surgical and survival outcomes. J Am Coll Surg 224 (5): 906-916,2017.
Creasy JM, Goldman DA, Gonen M, Dudeja V, Askan G, Basturk O, Balachandran VP, Allen PJ, DeMatteo RP, D'Angelica MI, Jarnagin WR: Predicting residual disease in incidental gallbladder cancer: Risk stratification for modified treatment strategies. J Gastrointest Surg : 2017.
Pak LM, Coit DG, Eaton AA, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Strong VE: Percutaneous peritoneal lavage for the rapid staging of gastric and pancreatic cancer. Ann Surg Oncol 24 (5): 1174-1179,2017.
Langan RC, Goldman DA, D'Angelica MI, DeMatteo RP, Allen PJ, Balachandran VP, Jarnagin WR: Recurrence patterns following irreversible electroporation for hepatic malignancies. J Surg Oncol : 2017.
Pak LM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran VP, Jarnagin WR: Natural history of patients followed radiographically with mucinous cysts of the pancreas. J Gastrointest Surg : 2017.
Sorenson EC, Khanin R, Bamboat ZM, Cavnar MJ, Kim TS, Sadot E, Zeng S, Greer JB, Seifert AM, Cohen NA, Crawley MH, Green BL, Klimstra DS: Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation. PLoS One 12 (5): e0176562,2017.